Drug Design Targeting T-Cell Factor (TCF)-Driven Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Strategy for Colorectal Cancer.
暂无分享,去创建一个
A. D’Alessandro | W. Messersmith | J. Schaack | T. Nemkov | K. Hansen | D. Gustafson | P. Lunghofer | Qiong Zhou | D. LaBarbera | Daniel V. LaBarbera | N. Tomlinson | Jose D. Gomez | S. Rinaldetti | D. Ramirez | Linfeng Li | Joshua M. Abbott | Hector Esquer | A. D. Abraham | L. Pike | Brayden D. Hamill | Adedoyin D. Abraham